Page 4 - Perioperative News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Perioperative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Perioperative Today - Breaking & Trending Today

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center. ....

United States , John Heymach , Lily Ramsey , Eli Lilly Co , Boehringer Ingelheim , American Association For Cancer Research , University Of Texas Md Anderson Cancer Center , Bristol Myers Squibb , Jazz Pharmaceuticals , Janssen Pharmaceuticals , Spectrum Pharmaceuticals , New England Journal , American Association , Cancer Research , Annual Meeting , Neck Medical Oncology , Mirati Therapeutics , Eli Lilly , Curio Science , Blueprint Medicines , Lung Cancer , Non Small Cell Lung Cancer , Small Cell Lung Cancer ,

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC). ....

United States , Tina Cascone , Megan Craig , European Society For Medical Oncology , University Of Texas Md Anderson Cancer Center , Bristol Myers Squibb , Medical Oncology , Neck Medical , Bristol Myers , Lung Cancer , Non Small Cell Lung Cancer , Small Cell Lung Cancer ,

Perioperative Nivolumab Improves EFS in Resectable NSCLC

Interim findings from CheckMate 77T show an overall improvement in event-free survival with perioperative nivolumab vs neoadjuvant nivolumab plus chemotherapy only. ....

United States , Marina Garassino , Bristol Myers Squibb , Tina Cascone , Thoracic Oncology Program , University Of Chicago , European Society For Medical Oncology , European Society , Medical Oncology , Cancer Medicine , Cancer Center , Non Small Cell Lung Cancer , Lung Cancer , Ung Carcinoma , Ancer Lung , Biologic Therapy In Cancer , Iological Therapy In Cancer , Iologics Cancer , Biologic Therapy , Monoclonal Antibody , Alignant Neoplasia , Oncological Medicine , Adjuvant Therapy , Iological Marker ,

The less-discussed threat to ASC growth

Regional administrator Les Jebson joins Becker s to discuss the threats to outpatient growth and procedures moving to ASC setting. He highlights systemic nation ....

Les Jebson , S Prisma Health , Prisma Health , Nurse Anesthetists , Registered Nurses ,

Two simple solutions could help prevent postpartum hemorrhage

Two simple solutions could help prevent severe bleeding (postpartum hemorrhage) after cesarean delivery, suggests research presented at the ANESTHESIOLOGY® 2023 annual meeting. ....

United States , Stanford University , James Xie , Jessica Ansari , Danielle Ellis , Drug Administration Approved , Alla Yarmosh , Blood Transfusion , Blood Vessels , Health Care ,